Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0000950149-06-000551
Filing Date
2006-11-27
Accepted
2006-11-27 17:26:22
Documents
4
Effectiveness Date
2006-11-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT f25142dedefm14a.htm DEFM14A 932035
2 GRAPHIC f25142def2514200.gif GRAPHIC 2347
3 GRAPHIC f25142def2514201.gif GRAPHIC 1746
4 GRAPHIC f25142def2514202.gif GRAPHIC 1002
  Complete submission text file 0000950149-06-000551.txt   941064
Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107 4155127624
SIRNA THERAPEUTICS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-27914 | Film No.: 061240205
SIC: 2834 Pharmaceutical Preparations